Thu, June 7, 2018
Wed, June 6, 2018
Tue, June 5, 2018
Mon, June 4, 2018
Fri, June 1, 2018
Thu, May 31, 2018
Wed, May 30, 2018
Tue, May 29, 2018
Fri, May 25, 2018
Thu, May 24, 2018
Wed, May 23, 2018
Tue, May 22, 2018
Mon, May 21, 2018
Fri, May 18, 2018
Thu, May 17, 2018
Wed, May 16, 2018
Tue, May 15, 2018
Mon, May 14, 2018
Fri, May 11, 2018
Thu, May 10, 2018
Wed, May 9, 2018
Tue, May 8, 2018

Elemer Piros Initiated (APLS) at Buy and Held Target at $52 on, May 24th, 2018


//stocks-investing.news-articles.net/content/201 .. -buy-and-held-target-at-52-on-may-24th-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Elemer Piros of Cantor Fitzgerald, Initiated "Apellis Pharmaceuticals, Inc." (APLS) at Buy and Held Target at $52 on, May 24th, 2018.

Elemer has made no other calls on APLS in the last 4 months.



There are 2 other peers that have a rating on APLS. Out of the 2 peers that are also analyzing APLS, 1 agrees with Elemer's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Madhu Kumar of "B. Riley Securities" Downgraded from Strong Buy to Hold on, Thursday, April 12th, 2018


This is the rating of the analyst that currently disagrees with Elemer


  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $35 on, Friday, March 23rd, 2018

Publication Contributing Sources